Overview

Teligene US LLC is a wholly owned subsidiary of Suzhou Teligene Ltd., dedicating to developing innovative small-molecule drugs. We have a pipeline of drug candidates at various clinical stages with potential advantage over existing therapeutics that are aimed at improving patient outcomes in conditions with significant unmet medical need.